Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Not Confirmed
Not Confirmed
31 July-02 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Industry Trade Show
Not Confirmed
31 July-02 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
28 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accuredit-therapeutics-art001-becomes-chinas-first-gene-editing-therapy-to-receive-fda-regenerative-medicine-advanced-therapy-rmat-designation-302468037.html
25 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accuredit-therapeutics-lnp-based-in-vivo-gene-editing-product-art001-obtained-orphan-drug-designation-from-the-fda-302410518.html
13 Jan 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/accuredit-therapeutics-and-n1-life-form-a-joint-venture-named-napoltec-dedicated-to-the-development-of-therapeutic-drug-delivery-systems-and-pressing-ahead-clinical-translation-301460130.html
29 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/accuredit-therapeutics-appointed-dr-fuxin-shi-as-head-of-new-drug-discovery--preclinical-research-and-general-manager-of-the-us-subsidiary-301432626.html
ABOUT THIS PAGE